Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 25, 2025 09:00 ET | Source: Altamira Therapeutics Ltd

Altamira Therapeutics to Host Full Year 2024 Financial Results and Business Update Call on April 30, 2025

Hamilton, Bermuda, April 25, 2025 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. ("Altamira" or the "Company") (OTCQB: CYTOF), a company dedicated to developing and commercializing RNA delivery...
January 22, 2025 09:00 ET | Source: Altamira Therapeutics Ltd

Altamira Therapeutics Announces Collaboration on Radiopharmaceutical Targeting Strategies

Hamilton, Bermuda, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Exploring use of Altamira’s RNA nanoparticles in conjunction with radiopharmaceutical cancer treatment Project collaboration partner will have...
August 12, 2024 09:02 ET | Source: Altamira Therapeutics Ltd

Altamira Therapeutics Announces Significant Enhancement of Immune Checkpoint Inhibition Therapy in Combination with Zbtb46 mRNA Delivered with SemaPhore Nanoparticles in Animal Tumor Models

Hamilton, Bermuda, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Treatment with ZbtbB46 mRNA nanoparticles based on Altamira’s SemaPhore™ delivery technology results in significant reduction in...
May 28, 2024 10:31 ET | Source: Altamira Therapeutics Ltd

Altamira Therapeutics Provides Business Update

Hamilton, Bermuda, May 28, 2024 (GLOBE NEWSWIRE) -- Achieved significant improvement in handling and transport stability of RNA nanoparticlesPursuing partnering opportunities with AM-125 legacy...